Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...

Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...

North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...

The World Bank’s ‘one stop shop’ bid to up investment. Plus, we list down the Inter-American Development Bank's top 10 ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

A novel asthma burden score that incorporated asthma exacerbations and healthcare utilization better reflected disease ...

As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the ...

The Competition Commission played a pivotal role in South Africa's historic fight for access to HIV medicines.

In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.